INTRODUCTION
Dystroglycan (DG) is a central component of the dystrophin associated protein complex (DAPC), a multimeric protein assembly that functionally connects the extracellular matrix to the actin-based cytoskeleton [1] DG is post-translationally cleaved into the extracellular -DG subunit and the transmembrane -DG subunit (reviewed in [2] ). -DG acts as a receptor for several extracellular matrix proteins, including laminin and other lamin G (LG) module-containing proteins, while -DG functions as a platform for different adhesion-related processes, including cytoskeleton remodeling [3, 4] , extracellular signal-related kinase mitogen-activated protein kinase (ERK-MAPK) signaling [5] , and controlling the dynamics of cellular adhesions in myoblasts [6] .
The recently unveiled nuclear localization of -DG expands the diversity of recognized functions of this protein; -DG is translocated to the nucleus in an importin (IMP) β/ 1-dependent fashion, through recognition of a nuclear localization signal (NLS) located in its juxtamembrane region [7, 8] . Nuclear -DG in turn interacts with the nuclear envelope (NE) proteins emerin and lamins A/C and B1, which enables it to modulate NE structure and function in myoblasts [9] . Thus, the broad range of localizations and mechanisms in which -DG is involved implies that trafficking of the protein may be tightly regulated to attain proper subcellular distribution in response to specific stimuli. Since -DG localizes to both plasma membrane and NE, we envisaged that -DG might have a functional nuclear export pathway that acts in coordination with the IMP β/ 1-mediated nuclear import to control cellular destination and regulate the concentration of the protein in each cell compartment.
In this study we show for the first time that there is an exportin1/Chromosome Region Maintenance 1 (CRM1)-mediated nuclear export pathway that regulates the ability of -DG to exit the nucleus via the recognition of a nuclear export signal (NES) located in the transmembrane domain of -DG. Remarkably, we demonstrated that abnormal nuclear accumulation of -DG alters both targeting at the NE and the proteins levels of lamin B1 and emerin, which in turn impairs various crucial cellular processes regulated by these two proteins. In summary, our data show that the combination of CRM1-dependent nuclear export and nuclear proteasome pathways prevent harmful nuclear accumulation of -DG, and consequently these mechanisms are physiologically relevant for proper NE organization and activity.
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MATERIAL AND METHODS
Cell culturing, treatments, and transfection
Mouse C2C12 myoblasts were acquired from ATCC, and grown as previously [9] . Mouse primary myoblasts were isolated and cultured as previously described [10] . For inhibition of nuclear protein export, myoblasts were treated for 5 h with 50 nM of Leptomycin B (LMB; Sigma-Aldrich, St Louis), diluted in ethanol 70% or with ethanol alone. For analysis of -DG stability, cells treated with ethanol (vehicle) or LMB as above were incubated with 30 µg/ml cycloheximide (CHX) (Sigma-Aldrich, St Louis) to inhibit protein synthesis. Cells were harvested at 0, 12, 24 and 30 h of CHX treatment for further analysis. The proteasome inhibitor MG132 (Sigma-Aldrich, St Louis), was used at 10 µM for 30 h. For transfection, C2C12 myoblasts seeded onto glass coverslips were incubated overnight prior to being transfected with γ g of the appropriate vector premixed with γ l of Lipofectamine β000 (Invitrogen, Carlsbad, CA, USA), following the supplier's protocol, and were analyzed 24 h post-transfection. For knockdown experiments, C2C12 cells were stably expressing with psi-mH1 vector expressing a small interfering RNA (RNAi) specific for mouse CRM1, with a scrambled RNAi as a control (GeneCopoeia, Inc., Rockville, MD). Stablytransfected C2C12 myoblasts were obtained by culturing them for 12 days in the presence of 2 µg/ml Puromycin (Invitrogen), prior to being used for further experiments.
Immunofluorescence and confocal microscopy analysis
Immunofluorescence assays were carried out as previously [11] , and cell preparations were analyzed on a confocal laser scanning microscope (TCS-SP2, Leica, Heidelberg, Germany), using a Plan Neo Fluor 63x (NA = 1.4) oil-immersion objective. Single optical sections were visualized to analyze colocalization between fluorescent markers. Analysis of digitized images were carried out using Fiji software [12] to determine the nuclear to cytoplasmic ratio (Fn/c), and nucleoli volume and 3D reconstruction.
Plasmids and antibodies
The eukaryotic expression vectors encoding GFP and GFP--DG were previously described [7] .
The mutant derivative GFP--DGNESm, which contains three-point mutations in the NES motif of -DG at I763A/L764A/L765A positions, was generated by standard site-directed mutagenesis techniques, using GFP--DG vector as the template, the high fidelity Herculase II Fusion DNA polymerase (Agilent Technologies, Santa Clara, CA), and the following oligonucleotides: forward 5'-GGTCGCGGCCGCCGCGGCCAT TGCTGGAATC-γ' and reverse 5'-GATTCCAGC-
AATGGCCGCGGCGGCCGCGACC-γ'. Vectors expressing GFP in frame with the NES motif of -DG and the retroviral protein REV were engineered using the following oligonucleotides: for GFP-NES -DG forward 5'-GATCCAATCCTGCTCATTGC-TGGCATCATTGCCATG-γ' and reverse 5'-GATCCATGGCAATGATGCCAGCAATGAG-CAG-GATTG-γ' flanked by EcoR1 and BglII sites respectively; for GFP-NESREV forward 5'-AATTCGCTACCACCGCTTGAGAGACTTACTCTTTAAG-γ' and reverse 5'-TCGACTT-AAAGAGTAAGTCTCTCAAGCGGTGGTAGCG-γ', flanked by SalI and EcoRI sites respectively. Annealed oligonucleotides for NES--DG and NESREV were cloned in frame into pQBI and pEGFP-C1 respectively, via standard restriction/ligation techniques. Vectors encoding Glutathione S-transferase (GST) alone or fused to -DG were previously described [9] . For knockdown experiments, psi-mH1 vector expressing either a small interfering RNA (RNAi) specific for mouse exportin1/CRM1 CRM1 or a scrambled RNAi control was acquired from GeneCopoeia, Inc. (Rockville, MD). All constructs were confirmed by DNA sequencing.
The following primary antibodies were used: rabbit polyclonal (JAF) [13] , rabbit polyclonal (Dystroglycan [p Tyr892]) [14] , goat polyclonal (C20), and mouse monoclonal (MANDAG2) [15] or ( 
Cell fractionation
To obtain cytosolic and nuclear lysates, cells were collected by centrifugation at 3,500g for 15 min at 4ºC, and resuspended in 1 ml TM buffer (10 mM Tris-HCl pH 8.0, 2 mM MgCl 2 , 0.5 mM PMSF), containing 1X complete protease and phosphatase inhibitors (2 mM Na 3 VO 4 , 10 mM Na 2 MoO 4 , and 25 mM NaF), and further incubated for 10 min on ice. To solubilize the homogenates, 2% Triton X-100/PBS was added to obtain 1% Triton X-100 final concentration, prior to incubation for 10 min on ice. Nuclei were separated from the cytosolic membranes using a glass Dounce homogenizer (30 strokes using the B pestle) and centrifuged at 3,500g for 15 min at 4ºC. The integrity of the nuclei without debris or cytoplasmic membranes was verified by observation under the light microscope. The supernatant containing the cytosolic fraction was separated, and the nuclear pellet was resuspended in 1 ml of buffer I (0.32 M Sucrose, 3 mM CaCl 2 , at 4,000g for 15 min in a swinging bucket rotor. The pellet was resuspended in 1 ml of ice-cold extraction buffer including 0.3 mg/ml of heparin, and incubated at 4°C for 1 h. The suspension was underlayed again with 4 ml of ice-cold sucrose cushion and centrifuged as above. The resulting pellet that correspond to the NE was resuspended in RIPA 1X buffer. The nucleoplasmic fraction, was obtained as previously [18] , purified nuclei were resuspended in 1 ml of ice cold 10% STM buffer and spun 2,000g for 15 min. The pellet was then resuspended in 2ml of hypotonic buffer [20mM HEPES pH 7.9, 5mM KCl, 1.5Mm DTT, 1X complete (Roche Applied Science) and 0.5
mM PMSF] and homogenization was performed by applying 20 strokes with a Dounce homogenizer. Nuclear homogenates were centrifuged at 6,300g for 15 min at 4ºC. The resulting pellet was resuspended in 2 ml of ice-cold extraction buffer and centrifuged at 100,000g for 45 min.
The supernatant that correspond to the nucleoplasm (soluble nuclear protein) extract was collected.
Immunoprecipitation and GST binding assay
GFP-based immunoprecipitation was performed using 500 µg of C2C12 cell lysates and the GFPTrap® bead system (Chromotek, Planegg, Germany), and following the manufacturer's instructions. GST-based pull-down assays were performed as previously described [19] . Briefly, an aliquot (20 ml) of transformed bacterial cells (strain BL21), induced with 0.1 mM IPTG for 2 h at room temperature, then were centrifuged at 2,000g for 10 min, resuspended in 1 ml of NETN buffer times with 0.5 ml ice-cold NETN buffer. Eluted proteins were subjected to SDS-PAGE and the interacting proteins were identified by western blotting analysis, using the appropriate primary antibodies.
Western blotting
Cell lysates were subjected to electrophoresis on 10% SDS-polyacrylamide gels and transferred 
Proliferation assay
Cells stably expressing GFP, GFP--DG or GFP--DGNESm were harvested and plated in triplicate onto 12 wells microplates at 1 x 10 2 cells/mL confluence. Cell proliferation was assessed for 13 days using the MTT [3-(4,5-dimethylthiazole)-2-5-diphenyl tetrazolium bromide] commercial kit (Sigma-Aldrich) and following the manufacturer's instructions.
Flow cytometry
Cells were released from the culture dish using trypsin, followed by pelleting and washing twice with PBS. Cells were then fixed with 80% ethanol for β hours, stained for DNA with 1 g/mL h, the levels of luciferase and Renilla luciferase were determined in a luminometer using the Dual Luciferase Reporter Assay kit (Promega, Madison, WI). Luciferase activity was normalized to
Renilla luciferase activity to adjust for transfection efficiency.
2.11.Statistical analysis
Statistical analyses were performed by the two tailed unpaired Student's t test with Welch's correction, using GraphPad Prism 6 software (La Jolla California USA, www.graphpad.com). Data represent the mean +/-SEM from a series of three or four separate independent experiments and P values < 0.05 are indicative of statistical significance.
RESULTS
-DG can shuttle between the nucleus and cytoplasm
Since -DG is distributed in both nuclear and non-nuclear fractions, it seems likely that it may be a nucleocytoplasmic shuttling protein with a functional nuclear export pathway. To assess whether -DG possess an exportin 1/CRM1-dependent nuclear export mechanism, the effect of the exportin CRM1-specific inhibitor leptomycin B (LMB) [21] on the subcellular distribution of -DG was evaluated in C2C12 myoblasts by confocal laser scanning microscopy (CLSM), using two different antibodies directed against the C-terminal domain of -DG: 7D11 (mouse monoclonal antibody) and pTyr892 (rabbit polyclonal antibody that specifically recognizes -DG phosphorylated at Y892 phosphorylated form undergo a CRM1-mediated nuclear export in myoblasts.
Nuclear export of -DG is mediated by a CRM1-recognized NES located in its transmembrane domain
CRM1-recognised nuclear export signals (NES) generally include 4 or more closely spaced hydrophobic residues, often leucines [22, 23] ; the primary amino acid sequence of -DG was analyzed in an attempt to identify a molecular signal responsible for nuclear export of -DG, using the NetNES 1.1 Server [24] . This analysis revealed a putative NES located in the transmembrane domain of -DG [25] , within residues 763 I LL I AG I IAM 772 ( Figure 2A ). The motif exhibits certain conservation among the orthologous proteins from different species (Figure 2A ), implying that the nuclear export property of -DG might be preserved through evolution. To assess NES functionality, we fused the NES of -DG to the heterologous protein GFP (see Methods), and ascertained whether the NES motif alone is able to mediate nuclear export of GFP. C2C12 myoblasts were transiently transfected to express GFP-NES -DG or GFP alone as control ( Figure   2B ), and the distribution of the fluorescent reporter proteins was examined by CLSM. GFP alone distributed between the cytoplasm and the nucleus, with a comparatively higher signal in the nucleus, and this localization was unchanged after LMB treatment ( Figure 2C These results imply that inclusion of the putative -DG NES motif was sufficient to confer upon GFP the ability to undergo nuclear export, and that this trafficking pathway is sensitive to LMB.
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Hydrophobic residues within the NES are required for protein export. Therefore, in order to identify key hydrophobic amino acids in the NES of -DG, we generated a three-residue mutant (I763A/L764A/L765A) in the context of full-length -DG fused to GFP. Afterwards, C2C12
myoblasts were transiently transfected to express GFP--DG or the mutant variant GFP--DGNESm ( Figure 2D ), and the distribution of fluorescent recombinant proteins was analyzed by CLSM. Strikingly, and in strong contrast to the even distribution of GFP--DG between the cytoplasm and nucleus, the NES mutant variant displayed significantly greater nuclear accumulation ( Figure 2E ), with Fn/c ratios of 1.0 and 2.5 respectively (right panel): The clear implication of these data is that triple mutation on the hydrophobic residues makes the NES unable to be recognized by the exportin CRM1. As LMB treatment failed to further increase the nuclear localization of GFP--DGNESm ( Figure 2E ), it appears that NES located in the transmembrane domain is the sole or major motif for nuclear export of -DG.
To directly demonstrate an interaction of -DG with exportin1/CRM1, in vitro pull-down assays were carried out, whereby GST and GST--DG recombinant proteins were expressed in E. coli ( Figure 3A , top panel), purified and immobilised on Sepharose prior to incubation with C2C12 total lysates and subsequent WB analysis. Consistent with CLSM data, CRM1 was found to bind GST--DG but not GST alone (bottom panel), implying the specificity of the interaction. To confirm that -DG binds exportin1/CRM1 in a physiological context and that such interactions occurs through the NES, we performed immunoprecipitation assays in intact cells using a GFPTrap approach. GFP--DG but not GFP alone immunoprecipitated endogenous CRM1 from lysates of transiently transfected C2C12 cells, and importantly, GFP--DGNESm, which is impaired in nuclear export (see Figure 2C ), was unable to interact with CRM1 ( Figure 3B ). Overall these data imply that CRM1 is the nuclear export transporter for -DG in living cells and that a NES located in the TM domain of -DG, mutated in GFP--DGNESm, is the target of CRM1.
To further demonstrate the dependence of -DG nuclear export on exportin-CRM1, we analyzed the impact of exportin 1/CRM1 knockdown on -DG subcellular localization. To this end, C2C12
myoblasts were transfected with a vector expressing small interfering RNA (RNAi) designed to target CRM1 mRNA or a scrambled RNAi that is predicted not to block the expression of any specific gene, as negative control. WB analysis of lysates obtained from cells stably expressing each RNAi ( Figure 3C ), and the subsequent quantitative analysis (bottom panel) showed that the CRM1 RNAi was effective in depleting exportin CRM1 protein levels, resulting in a decrease of 70%. It is worth to note that knockdown of CRM1 may affect nuclear export of over 230 identified cargos [26] , with unpredictable consequences to cell physiology. We found -DG to accumulate in
the nucleus of CRM1-depleted cells to a greater extent than control RNAi cells ( Figure 3D ), with quantitative analysis corroborating these observations (bottom panel; Fn/c of 1.0 and 4.5 for cell expressing control RNAi and exportin 1 CRM1 RNAi respectively). Thus, -DG traffics from the nucleus to cytoplasm in an exportin-1/CRM1-dependent fashion.
The localization of -DG in the NE [9, 11] as well the presence of the NES in the TM region raised important questions about the mechanism that allows -DG to be available to be exported by CRM1. Since -DG localizes to both NE and nucleoplasm, we speculate that solely the nucleoplasmic fraction of -DG is undergoing nuclear export, while the NE-bound fraction of -DG is inaccessible to CRM1. To test this hypothesis, C2C12 cells were treated with LMB prior to being fractionated into NE and nucleoplasmic extracts. The cell fractions purity was validated by immunodetection of nucleoplasm (Sp3) and NE (emerin) protein markers. Consistent with our hypothesis, inhibition of nuclear export resulted in accumulation of -DG in the nucleoplasm; in contrast, -DG NE levels by contrast, remained unaltered after LMB treatment ( Figure 3E ).
Impaired nuclear export of -DG affects the levels and NE targeting of lamin B1 and emerin but not lamin A/C
From the above data, it appears that nuclear levels of -DG are tightly regulated by the balance of nuclear import/export mechanisms. Therefore, we anticipated that abnormal accumulation of -DG in the nucleus might alter nuclear envelope organization [9] . To test this hypothesis, we analyzed the impact of -DG nuclear accumulation on the distribution of NE proteins. To this end, cells were transiently transfected to overexpress GFP--DG or its shuttling-defective variant GFP--DGNESm. To validate the use of recombinant proteins, we fist ascertained whether GFP--DG and GFP--DGNESm target to the NE and bind to emerin and lamins A/C and B1, as endogenous nuclear -DG does [9] . CLSM analysis showed that GFP--DG and GFP-NESm localizes to the cytoplasm and nucleus and exhibited a nuclear ring-like staining that suggest their targeting to the NE ( Figure 4A ). To confirm this, cells were fractionated into NE lysates and further analyzed by SDS/western blotting. GFP--DG and GFP--DGNESm were recovered in the NE fraction of these cells, together with the nuclear envelope protein marker emerin. The nucleoplasmic marker Sp3 is absent in the NE extract, which confirmed purity of this fraction ( Figure 4B ). Consistently, GFPbased IP assays demonstrated that both GFP--DG and GFP--DGNESm but not GFP alone, as we have seen before. Conversely, the majority of cells expressing GFP--DGNESm exhibited altered immunostaining for both lamin B1 and emerin, which consist of a marked decrease in the NE staining, with the residual signal localized in discrete aggregates outside the nucleus ( Figure   5A ). Quantification of cells with emerin/lamin B1 mislocalization confirming these observations (right panels). The distribution of lamin A/C remained largely unaltered in GFP--DG NESmexpressing cells suggesting that nuclear accumulation of -DG affects specifically emerin and lamin B1, as has been seen for nuclear depletion of -DG [9] . Expression of GFP--DGNESm in a transient fashion resulted in a less severe mislocalization and protein aggregation for emerin and lamin B1 (Supplemental Figure. 2 ). To evaluate whether mislocalization of NE proteins impacts their protein levels, lysates from C2C12 cells stably expressing GFP, GFP--DG or GFP--DGNESm were analyzed by western blotting with antibodies specific to each NE protein ( Figure   5B ). Quantitative analysis of immunoblots employing calnexin as loading control, revealed that nuclear accumulation of -DG resulted in a substantial decrease of lamin B1 (~45%), emerin (~55%) and lamin A (~20%) levels (lower panel). Since the mRNA levels of the NE proteins estimated by RT-qPCR were found to be unaltered in cells stably expressing the shuttling-defective mutant ( Figure 5C ), it appears that a post-transcriptional mechanism underlies the depletion of emerin, lamin B1 and lamin A levels. This suggests therefore that nuclear accumulated -DG associates quite strongly with the NE proteins, sufficient to disrupt endogenous NE architecture.
Nuclear accumulation of -DG compromises emerin-mediated processes
We tested the hypothesis that abnormal nuclear accumulation of -DG, with concomitant mislocalisation and decreased levels of emerin, might compromise emerin function. Attachment of centrosomes to the outer nuclear membrane has been shown to depend, at least in part, on a microtubule-emerin pathway [27] , we therefore analyzed whether expression of the -DG shuttlingdefective mutant affects centrosome linkage to the nucleus ( Figure 6A ). Interestingly, cells expressing GFP--DGNESm exhibited a significant increase in the centrosome-nucleus distance (mean value of 2.811 µm), compared with cells expressing either GFP (mean value of 1.537 µm) or GFP--DG (mean value of 1.999 µm). In addition, since emerin promotes nuclear export ofcatenin and thereby down-regulates -catenin transcriptional activity [28] , we examined the distribution and activity of -catenin in CβC1β cells stably expressing the -DG shuttling-defective mutant. Levels of nuclear -catenin were consistently low in control cells expressing either GFP or GFP--DG; whereas cells expressing GFP--DGNESm with accompanying mislocalization of
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emerin, exhibited a more predominant nuclear staining of -catenin ( Figure 6B ). To further demonstrate the effect of dystroglycan on stability of emerin, -catenin transcriptional activity was measured by transfecting a reporter vector in which luciferase expression is controlled by a promoter containing multiple -catenin-TCF DNA elements (TOPGLOW), with a mutant promotercontaining vector (FLOPGLOW) used as control. We saw a more than 2-fold increase in -catenin activity in cells expressing GFP--DGNESm, compared with control cells ( Figure 6C ). Overall these data suggest that displacement of emerin from the NE, due to altered nuclear export of -DG, ultimately undermined secondary functions of emerin including centrosome positioning and control of the transcriptional activity of -catenin.
Expression of the -DG shuttling defective mutant impairs lamin B1-dependent processes
Since lamin B1 is crucially involved in cell cycle progression [29] , we were prompted to ascertain whether expression of the nuclear export-defective mutant of -DG leads to an impairment of this process. In keeping with our hypothesis, a marked delay in the growth rate of GFP--DGNESmexpressing cells was noted compared to untransfected cells, or cells expressing GFP--DG or GFP alone ( Figure 7A ). The delayed growth rate of GFP--DGNESm expressing cells appeared to be due to a delay in G0/G1 phase rather than S-phase, as GFP--DGNESm expressing cells showed a significant increase in G0/G1 when released from serum starvation ( Figure 7B ) whereas when released from thymidine block there was no difference in S phase progression between GFP--DGNESm and GFP--DG or GFP expressing cells ( Figure 7C ). Lamin B1 is also involved in the maintenance of nucleolar architecture [30] then, C2C12 cells were arrested in late G1/early S phase by double thymidine treatment ( Figure 7D ), prior to evaluate the nucleolar structure. Consistent with the ability of -dystroglycan to affect lamin B1 localisation, increased nuclear accumulation of GFP--DG NESm resulted in disaggregation of nucleoli into more numerous and smaller bodies as determined by immunostaining for the nucleolar protein fibrillarin. This was further confirmed by both 3-D reconstruction of nucleoli structure ( Figure 7E ) and estimation of nucleoli number and nucleolar volume ( Figure 7F ). These data demonstrate that hindering -DG nuclear export, with concomitant alteration of lamin B1 localization and expression, results in altered cell cycle progression and distorted nucleolar organization.
Forced nuclear accumulation of -DG enhances its proteasomal degradation in the nucleus
The lifespan of -DG has been shown to be modulated by phosphorylation-dependent proteosomal degradation [31] . Therefore we were prompted to analyze whether -DG stability depends on its subcellular compartmentalization. C2C12 cells were pretreated with leptomycin B (LMB) prior to
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15 inhibiting protein synthesis with cycloheximide, to analyze whether nuclear accumulation of -DG affects its turnover. Interestingly, we observed a drastic reduction of 50% in the half-live of -DG upon LMB treatment ( Figure 8A ) and this decrease in the protein levels was reversed after MG132 treatment ( Figure 8B ), suggesting that -DG is more prone to proteosomal degradation within the nucleus. Because ubiquitination is an essential step for further degradation by the proteasome, we monitored the ubiquitination of -DG in both the cytoplasm and the nucleus. C2C12 lysates were subjected to pulldown with GST-MultiDsk a GST protein fused to 3 repeated ubiquitin binding domains [20] . A higher molecular weight band that is likely to correspond to ubiquitinated -DG was pulled down by the MultiDsk protein in both cytoplasm and the nucleus, but it was only recognised by the antibody raised against tyrosine phosphorylated -dystroglycan and not by the antibody that detects unphosphorylated dystroglycan ( Figure 8C ). Thus, as has been described previously [31] , it is only the tyrosine phosphorylated form of -DG that is ubiquitinated. It is noteworthy that in this study, virtually all nuclear p -DG was found to be ubiquitinated in the LMB-treated cells (compare S to P fractions), suggesting a more active ubiquitination of -DG is in these cells. Overall these data imply that -DG is degraded by both the cytoplasmic and the nuclear proteasome and that forced nuclear accumulation of p -DG enhances its nuclear degradation.
Discussion
-dystroglycan ( -DG) is a well characterized component of the dystrophin associated protein complex (DAPC) of the sarcolemma with critical functions in cell adhesion/signaling and cytoskeleton remodeling [3, 5, 6, 32] . More recently, it has also been found to translocate to the nucleus in an importin β/ 1-dependent fashion [7, 8] . In the nucleus, -DG is thought to assemble with emerin and lamins A/C and B1 and plays a role in regulating nuclear architecture [9] . In this study, we investigated the nuclear export of -DG and demonstrate for the first time that -DG is subject to nucleocytoplasmic shuttling with an active exportin1/CRM1-mediated nuclear export pathway that together with its nuclear import serves to tightly regulate the nuclear levels of -DG.
In addition, we provide evidence that control of nuclear -DG content by both nuclear export and nuclear proteasomal degradation pathways is physiologically relevant to maintain proper nuclear envelope organization and activity.
We identified a consensus hydrophobic nuclear export signal (NES) in the transmembrane region of -DG. Using site-directed mutagenesis of GFP--DGNES fusion proteins we determined that the NES was functional. Nuclear export of -DG was shown to be dependent on exportin1/CRM1, as demonstrated by: i) the CRM1-specific inhibitor Leptomycin B (LMB) blocked nuclear export of -
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16 DG in either C2C12 or primary myoblasts; ii) knockdown of exportin/CRM1 expression resulted in nuclear accumulation of both endogenous -DG and GFP--DG fusion protein and iii) specific interaction of -DG with exportin/CRM1 was revealed by either in vitro pull down assays and GFPbased immunoprecipitation assays in living cells. Overall these results support the notion that nuclear export of -DG relies on NES motif recognition by exportin1/CRM1. To our knowledge, -DG represents a unique example of an inner nuclear membrane protein with functional nuclear export pathway. We found that solely the nucleoplasmic fraction of -DG is undergoing nuclear export, while the NE-bound fraction of -DG remained inaccessible to CRM1. These results imply the existence of a molecular mechanism enabling -DG to reach the nucleoplasm to be then accessible to the CRM1 nuclear export machinery. Elucidation of such mechanisms clearly requires further investigation [33] .
Dystroglycan has multiple cellular roles involved in cell adhesion, cell signaling and organization of the cytoskeleton [2] . The spatial and temporal segregation of these multiple activities at the plasma membrane is under tight control, including by tyrosine phosphorylation, ubiquitination and regulated proteolysis [34] [35] [36] [37] and through its association with a number of different cytolinker proteins depending on context [2] . Perturbations in dystroglycan homeostasis are evident in diseases such as muscular dystrophies [38] and cancer [39] . Moreover experimental manipulation of cellular dystroglycan levels by RNAi-mediated knockdown or overexpression can have both loss of function and gain of function consequences for cell adhesion, cell migration, cell invasion, anchorage independent growth and cytoskeletal organization [6, 36, 40] . The targeting of dystroglycan to different cellular compartments also impacts on function. Tyrosine phosphorylation of dystroglycan results in internalization of -DG from the plasma membrane to the cytosol, where it can be targeted to endosomes [35, 41] . We recently demonstrated that -DG undergoes retrograde trafficking from the PM to the nucleus, via the endosome-endoplasmic reticulum (ER) network.
With the assistance of Sec61 -DG is able to exit the ER membrane and becomes accessible for importin-mediated nuclear import through the nuclear pore [33] . Alternatively, we propose that -DG transits by lateral movement from ER to the NE, where the Sec61 localized in the NE could protein into a complex increases its stability [42, 43] .
The tight regulation of dystroglycan function therefore extends to the nuclear compartment, as either nuclear accumulation (shown here by blocking nuclear export) or nuclear depletion of -DG [9] leads to aberrant nuclear architecture. It is likely that an excess of nuclear -DG results in competition between lamin B1 and emerin possibly leading to non-functional pairwise interactions with -DG rather than functional three-way interactions, whereas sub-stoichiometric levels of -DG don't allow enough three way interactions to form, the net result in either case being mislocalisation of emerin and lamin B1 and loss of NE architecture (Figure 4) . A similar scenario is observed at the sarcolemma where mis-expression of sarcospan, caveolin-3 and plectin leads to competition for binding sites between these proteins and dystroglycan and dystrophin [44] [45] [46] . The nuclear accumulation of -DG disturbs emerin-and lamin B1-dependent functions (Figure 6-7) . A significant percentage of CβC1β myoblasts containing high concentration of nuclear -DG exhibited centrosomes that were detached from the NE, implying that the microtubule-emerin pathway that controls anchorage of centrosomes to the ONM [27] was disrupted in these cells.
Furthermore, transcriptional activity of -catenin, which is partially dependent on emerin-mediated nuclear export of -catenin [28] , was increased in cells containing an excess of nuclear -DG. In the same way, we found impairment in the lamin B1 activities that control cell cycle progression and nucleoli structure in response to high levels of nuclear -DG. These cells accumulate at G0/G1 and exhibited delay transition through S phase, which is consistent with a previous study showing prolonged S phase in colon cancer cells with depleted levels of lamin B1 [29] . Interestingly the same effect on the cell cycle is seen in Swiss 3T3 cells depleted for dystroglycan [47] . With respect to the nucleolar compartment, we observed the appearance of dispersed and distorted nucleoli concomitant with the nuclear accumulation of -DG. This is probably due to the role of lamin B1 in modulating nucleoli organization and plasticity [30] , it is likely that nuclear overexpression of -DG impacts nucleoli structure by a primary effect upon lamin B1 expression, localization, interactions and stability. Altogether, these data demonstrate that dysregulation of -DG nuclear trafficking has physiological consequences on NE organization and activity. In keeping with this idea, cells treated with LMB exhibited accelerated turnover of nuclear -DG, by nuclear proteosomal degradation, which suggests the activation of alternative protective mechanisms to restrict the lifespan of nuclear -DG and prevent its harmful accumulation.
It has been observed previously that alterations in the protein levels of one NE component, either by knockdown or overexpression can have deleterious effects on other NE components with which it interacts, with functional and pathological consequences [48] . Lamin B1 overexpression in oligodendrocytes resulted in both altered localization and protein levels of LAP2 (LaminaAssociated Polypeptide 2) and decreased nuclear import of Nup153. [49] . Dosage-sensitivity of the lamin B1-containing NE network is highlighted by the fact that adult-onset autosomal dominant leukodystrophy (disorder characterized by central nervous system demyelination) is caused by lamin B1 overexpression, due to LMNB1 gene duplication [50, 51] . In opposite way, lamin B1
knockdown induced cell senescence in human fibroblasts [52] . Furthermore, either overexpression or downregulation of LUMA (transmembrane protein 43) has a drastic effect on NE structure via mislocalization of emerin [53] . Likewise, decreased emerin levels by antisense treatment resulted in altered centrosome-nucleus distance [27] . Finally, nuclear accumulation of RAC1
(member of the Rho family of small GTPases that localizes in the NE) due to an alteration in its nuclear export pathway, leads to actin polymerization-dependent alterations in NE organization, including aberrant nuclear shape and mislocalization of lamin A/C and emerin, and ultimately to acquisition of a cell invasive phenotype [54] . Therefore, by similar mechanisms, changes in dystroglycan through altered nuclear trafficking, lead to alterations in nuclear architecture.
Several transmembrane surface receptors are known to translocate to the nucleus, either in whole or in part. Cleavage of the intracellular domain (ICD) of several adhesion receptors, such as notch and CD44 and the translocation of the ICD to the nucleus is an integral part of their signalling mechanism. Like -dystroglycan, the ICD of notch and CD44 have roles in regulating transcriptional activity in the nucleus [55] [56] [57] . Tyrosine kinase receptors such as EGFR and FGFR, and GPCRs like the bradykinin B2 receptor are translocated to the nucleus intact [58] [59] [60] [61] [62] . The role of the FGFR in the nucleus remains unclear, whereas translocation of the EGFR and bradykinin B2
receptors to the nucleus are believed to also have a role in transcriptional regulation [63, 64] . But unusually -dystroglycan is also translocated to the nucleus intact, where it functions in the NE as a nuclear cytoskeletal anchor, in a manner similar to its role in the plasma membrane [2] . Possibly, because of the dual role that -dystroglycan plays in the plasma membrane and the NE, and the fact that -dystroglycan translocates from plasma membrane to nucleus where increased levels of dystroglycan can have deleterious effects, as we have shown here, -dystroglycan is also actively degraded or exported from the nucleus. The mechanism of export involves the normal nuclear export pathway via CRM1, but somewhat unusually involves an NES that is part of the transmembrane region of dystroglycan. However, such a mechanism is not without precedent.
Experiments conducted by Myers and colleagues [65] , demonstrated a role for the transmembrane region of FGFR in nucleo-cytoplasmic shuttling. Moreover, reviewing their data in the context of current understanding of NES [66] , it seems clear that nuclear accumulation of FGFR mutants they generated is due to alteration of a putative NES in the transmembrane region of FGFR1 ( In conclusion, we show that -DG is a nucleus/cytoplasm shuttling protein with a functional nuclear export pathway that depends on the recognition of a NES localized in its transmembrane domain by exportin/CRM1. Remarkably, exportin 1/CRM1 nuclear export and nuclear proteasomal degradation pathways contribute both to control -DG nuclear content, in order to preserve the structure and functioning of the NE (Figure 9 ).  Nuclear export of -dystroglycan is mediated by exportin CRM1.
A C C E P T E D
 Forced nuclear accumulation of -dystroglycan altered the localization and levels of emerin and lamin B1.  Nuclear accumulation of -dystroglycan disrupted nuclear processes in which emerin and lamin B1 are critically involved.  The nuclear content of -dystroglycan is regulated by the nuclear export and nuclear proteasome pathways.  Control of -dystroglycan nuclear content is crucial for nuclear envelope structure and function.
